← back to search

Sabine Yerly

University of British Columbia · CH
Area of research
Infectious Diseases · Virology
Research interest
Research interests include HIV Research and Treatment, HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, and HIV-related health complications and treatments.
h-index
74
citations
19,492
works
460
NIH funding
primary concept
Medicine
email

Recent publications

Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells
Nature Medicine 2024cited by 48position: middledoi
A highly virulent variant of HIV-1 circulating in the Netherlands
Science 2022cited by 74position: middledoi
Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study
Clinical Microbiology and Infection 2021cited by 155position: middledoi
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
The Lancet 2020cited by 1,136position: middledoi
Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland
The Lancet Infectious Diseases 2020cited by 177position: middledoi
Resistance‐associated substitutions in patients with chronic hepatitis C virus genotype 4 infection
Journal of Viral Hepatitis 2020cited by 14position: middledoi
Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART
Nature Communications 2019cited by 186position: middledoi
The global spread of HIV-1 subtype B epidemic
Infection Genetics and Evolution 2016cited by 55position: middledoi
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study
Journal of Antimicrobial Chemotherapy 2013cited by 45position: middledoi
Role of retroviral restriction factors in the interferon-α–mediated suppression of HIV-1 in vivo
Proceedings of the National Academy of Sciences 2012cited by 118position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Klara M. Posfay‐Barbe · University of Geneva2 papers (2020–2021)Laurent Kaiser · Kantonsspital Aarau2 papers (2020–2021)Nicolas Vuilleumier · University of British Columbia2 papers (2020–2021)Benjamin Meyer · University Hospital of Geneva2 papers (2020–2021)Isabella Eckerle · German Cancer Research Center2 papers (2020–2021)Constance Delaugerre · Institut de recherche Saint-Louis1 papers (2013–2013)Christiane S. Eberhardt · University of Geneva1 papers (2021–2021)Arnaud G. L’Huillier · University of Lausanne1 papers (2021–2021) · 1 papers (2020–2020)Julian Schulze zur Wiesch · Universität Hamburg1 papers (2020–2020)Véronique Avettand-Fènoël · Institut Pasteur1 papers (2024–2024)Didier Pittet · Médecins Sans Frontières1 papers (2020–2020) · 1 papers (2013–2013)Claire‐Anne Siegrist · University of Geneva1 papers (2021–2021)Julia Dietz · Goethe University Frankfurt1 papers (2020–2020)Anaïs Chapel · Institut Pasteur1 papers (2024–2024) · 1 papers (2021–2021) · 1 papers (2013–2013)Olga Kalinina · Federal Almazov North-West Medical Research Centre1 papers (2020–2020)Paul Thoueille · University of Lausanne1 papers (2024–2024)